openPR Logo
Press release

Exocrine Pancreatic Insufficiency Market 2013

05-30-2017 01:28 AM CET | Health & Medicine

Press release from: Transparency Market Research

Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023.

Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep, Pancreaze, Ultresa, Viokase, Pertzye) and Phase III Drugs; Diagnostic Test – Blood Tests, Endoscopic ultra-sonography, MRI, and CT Scanning) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023 report at http://www.transparencymarketresearch.com/exocrine-pancreatic-insufficiency.html
Exocrine pancreatic insufficiency (EPI) is a condition characterized by the deficiency of the exocrine pancreatic enzymes, causing failure to digest food properly. Exocrine pancreatic insufficiency is caused due to damage to pancreas. The common causes of EPI are cystic fibrosis, chronic pancreatitis, and Shwachman-Diamond syndrome. The peculiar symptoms of EPI include frequent diarrhea, weight loss, foul-smelling greasy stools, gas and bloating, and stomach ache. Exocrine pancreatic insufficiency is treatable with pancreatic enzyme replacement therapy, which helps in digestion, improves malabsorption and vitamin deficiencies, and fuels weight gain.

Pancreatic enzyme replacement therapy products contain a defined amount of digestive enzymes such as lipases, proteases, and amylases, which are required by the body to metabolize fats, proteins, and sugar from food. Without these enzymes, patients with EPI are less capable of absorbing vital nutrients from food and can become undernourished. Effective management of EPI includes life-long pancreatic enzyme replacement therapy (PERT), lifestyle modifications, modifications with specialized food supplements such as vitamins and nutrients that do not require pancreatic enzymes for digestion, and transplantation of pancreatic cells.

Factors such as the increasing prevalence of diseases such as cystic fibrosis, chronic pancreatitis and diabetes are contributing to an increase in the prevalence of exocrine pancreatic insufficiency. According to recent data released by the Cystic Fibrosis Foundation, about 30,000 people are living with cystic fibrosis in the U.S. and 70,000 across the globe. Approximately 1,000 new cases of cystic fibrosis are diagnosed each year in the U.S. With such alarming rise in the number of people suffering from cystic fibrosis, the risk of incidence related to the disease also increases. People suffering from cystic fibrosis face breathing complications as mucus clogs their lungs and makes them susceptible to infections. Thick mucus also chokes the pancreas and obstructs the release of digestive enzymes leading to the deficiency of these enzymes. EPI is observed in a considerable proportion among the CF patients, with roughly 50% of children with CF suffering from this condition at birth. In addition, 25% of the population develops EPI within the first six months of life. Furthermore, 15% develop EPI in late childhood. According to recent data released by Aptalis (Allergan), chronic pancreatitis is observed in roughly 0.03% to 0.04% adults in the U.S. Of these, around 30% to 40% are expected to develop EPI over a span of 10 years.

Prevalence of EPI is expected to rise due to increase in the number of people suffering from diabetes. According to data published by the Centers for Disease Control and Prevention in 2014, the prevalence of diabetes in the U.S. has increased from 4.40% in 2000 to 7.18% in 2013. Examinations of people suffering from diabetes have shown greater than normal inflammation and damage to pancreatic tissue, signifying the increase in the risk of exocrine pancreatic insufficiency in people suffering from diabetes. The EPI market is also driven by the opportunities offered by developing countries. With an increasing incidence of diseases in this region, demand for PERT products is expected to grow in the next few years. However, stringent FDA regulations for the approval of PERT products are expected to hamper the growth of this market.

Major players in this market are AbbVie, Inc. (U.S.), Allergan plc (Ireland), Nordmark Arzneimittel GmbH & Co. KG (Germany), Digestive Care, Inc. (U.S.), Cilian AG (Germany), Anthera Pharmaceuticals, Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), and AzurRx BioPharma, Inc. (U.S.).

Get accurate market forecast and analysis on the Exocrine Pancreatic Insufficiency Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2748

Global exocrine pancreatic insufficiency market has been segmented as follows:

Global Exocrine Pancreatic Insufficiency Market, By Therapeutic
Introduction
Pancreatic Enzyme Replacement Therapy (PERT) products
Creon
Zenpep
Pancreaze
Ultresa
Viokace
Pertzye
Phase III drugs
Sollpura (Liprotamase)
Global Exocrine Pancreatic Insufficiency Market, By Diagnostic Test
Introduction
Blood Tests
Endoscopic Ultra-sonography (EUS)
Magnetic Resonance Imaging (MRI)
CT Scanning
Global Exocrine Pancreatic Insufficiency Market, By Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Rest of the World
South Africa
Russia
Rest of Rest of the World

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Sudip. S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exocrine Pancreatic Insufficiency Market 2013 here

News-ID: 555435 • Views: 513

More Releases from Transparency Market Research

Ion Exchange Resins Market to reach US$ 3,827.6 Mn by 2026
Albany, NY - According to a Transparency Market Research Report, the competition in the global ion exchange resins market is marked by fierce competition. Most players are expanding their product line with growing application for ion exchange resins. On the other hand, with some section of applications in scaling up, companies in the ion exchange market are working on developing techniques for large scale production of the product. Furthermore, the global
Recycled Metal Market to Reach US$ 979 Billion by 2026
Albany, NY - The recycled metal market was valued at US$ 713.44 Bn in 2017 is anticipated to expand at a CAGR of 3.5% during the forecast period, according to a new report published by Transparency Market Research (TMR) titled ‘Recycled Metal Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026’. Expansion in the recycled metal market is primarily driven by the increase in awareness about
Powder Metallurgy Market to expand at a CAGR of 6.8% by 2026
Albany, NY - Transparency Market Research (TMR) witnesses that the global powder metallurgy market has a consolidative vendor landscape owing to the dominance of few players. The key players operating in the global powder metallurgy market are GKN Hoeganaes, Sumitomo Electric Company Ltd, H.C. Starck, Sandvik AB, and Hitachi Chemical Company Ltd. Top three companies such as Sumitomo Electric Company Ltd, Fine Sinter Company Ltd, and GKN Hoeganaes collectively accounted for 35%
Wood Activated Carbon Market worth US$ 1,571.84 Mn by 2026
Albany, NY - According to a new report titled ‘Wood Activated Carbon Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,’ published by Transparency Market Research (TMR), the global wood activated carbon market was valued at US$ 785.80 Mn in 2017 and is anticipated to expand at a CAGR of 8.1% from 2018 to 2026. The global wood activated carbon market is driven by stringent regulations on mercury emission from

All 5 Releases


More Releases for EPI

Polish Data Centers Awarded Europe's First DCOS Certification by EPI
Atman, Warsaw Data Centers raises the bar on data center services in Poland and Europe with the first DCOS certification. Warsaw (d m, 2020) - Atman recently received the Data Centre Operations Standard (DCOS) Maturity Level-4 Certification from EPI. DCOS is a global standard covering all aspects for the operational management of a data center, confirming its high level of reliability, continuity of operations, safety and security. Atman became the
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market Opportunity Analysis …
Exocrine pancreatic insufficiency (EPI) is a condition associated with deficiency of exocrine pancreatic enzymes that results in the inability to digest food or maldigestion. EPI may be associated with certain diseases and conditions that affect the pancreas such as cystic fibrosis, chronic pancreatitis, Shwachman–Diamond syndrome, and others. Chronic pancreatitis (CP) is the most common cause of EPI in adults that is followed by cystic fibrosis (CF). CF is an inherited
Global Epi Wafer Market 2018 - Nichia, EpiWorks, Norstel, OMMIC
Eminent Market, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
United States Epi Wafer Market: Moving Towards a Brighter Future
Qyresearchreports include new market research report Epi Wafer to its huge collection of research reports. The report here assembles exchange points of view having a place with the United states Epi Wafer market which verbalizes the present-day information and future exposures with reference to the dynamic forces at play. The prime explanation for the examination report is to offer the endorser with a wide outline and make open the satisfying substances
Epi Wafer Market 2017 - GlobalWafers, Nichia, EpiWorks
Apex Research, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on